Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer

Journal of the American College of Surgeons

Volumn 202, Issue 1, 2006, Pages 139-145

  Tomimaru, Yoshito ^a   Yano, Masahiko ^a   Takachi, Ko ^a   Kishi, Kentaro ^a   Miyashiro, Isao ^a   Ohue, Masayuki ^a   Ohigashi, Hiroaki ^a   Sasaki, Yo ^a   Ishikawa, Osamu ^a   Imaoka, Shingi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERCOAGULABILITY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 29344454335     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2005.08.008     Document Type: Article

References (40)

1. rd ed. 1865 J-B Balliere et Fils Paris 654 712
2. D. Ferrigno, G. Buccheri, I. Ricca Prognostic significance of blood coagulation tests in lung cancer Eur Respir J 17 2001 667 673
3. G. Buccheri, D. Ferrigno, C. Ginardi Haemostatic abnormalities in lung cancer prognostic implications Eur J Cancer 33 1997 50 55
4. R.L. Bick Coagulation abnormalities in malignancy a review Semin Thromb Hemost 18 1992 353 372
5. R. Hoffman, N. Haim, B. Brenner Cancer and thrombosis revisited Blood Rev 15 2001 61 67
6. F.R. Rickles, A. Falanga Molecular basis for the relationship between thrombosis and cancer. Thromb Res 102 2001 215 224
7. N. Levitan, A. Dowlati, S.C. Remick Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 1999 285 291
8. A.K. Kakkar, N. DeRuvo, V. Chinswangwatanakul Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor Lancet 346 1995 1004 1005
9. E.C. Gabazza, O. Taguchi, T. Yamakami Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer Eur J Cancer 30A 1994 1276 1281
10. R. Seitz, N. Rappe, M. Kraus Activation of coagulation and fibrinolysis in patients with lung cancer relation to tumour stage and prognosis Blood Coagul Fibrinolysis 4 1993 249 254
11. F. Robert, E. Busby, M.B. Marques Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer preliminary results Lung Cancer 42 2003 237 245
12. L.R. Zacharski, W.G. Henderson, F.R. Rickles Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75 Cancer 53 1984 2046 2052
13. B. Lebeau, C. Chastang, J.-M. Brechot Subcutaneous heparin treatment increases survival in small cell lung cancer Cancer 74 1994 38 45
14. L.R. Zacharski, V.A. Memoli, V. Costantini Clotting factors in tumor tissue implications for cancer therapy Blood Coagul Fibrinolysis 1 1990 71 78
15. G. Buccheri, P. Torchio, D. Ferrigno Plasma levels of D-dimer in lung carcinoma clinical and prognostic significance Cancer 97 2003 3044 3052
16. G. Xu, Y.L. Zhang, W. Huang Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients World J Gastroenterol 10 2004 922 923
17. K. Blackwell, H. Hurwitz, G. Lieberman Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma Cancer 101 2004 77 82
18. L.Y. Dirix, R. Salgado, R. Weytjens Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer Br J Cancer 86 2002 389 395
19. th ed. 1993 JB Lippincott, Inc Philadelphia 75 79
20. C. Rella, M. Coviello, N. De Frenza Plasma D-dimer measurement as a marker of gynecologic tumors comparison with Ca 125 Tumori 79 1993 347 351
21. J. Nakashima, M. Tachibana, M. Ueno Tumor necrosis factor and coagulopathy in patients with prostate cancer Cancer Res 55 1995 4881 4885
22. H. Kato, T. Torigoe Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma Cancer 40 1977 1621 1628
23. J.C. Alexander Jr, P.B. Chretien, A.L. Dellon CEA levels in patients with carcinoma of the esophagus Cancer 42 Suppl 3 1978 1492 1497
24. E. Munck-Wikland, R. Kuylenstierna, J. Lindholm Carcinoembryonic antigen, CA 19-9 and CA 50 in monitoring human squamous cell carcinoma of the esophagus Anticancer Res 10 1990 703 708
25. E. Munck-Wikland, R. Kuylenstierna, B. Wahren Tumor markers carcinoembryonic antigen, CA 50 and CA 19-9 and squamous cell carcinoma of the esophagus. Pretreatment screening Cancer 62 1988 2281 2286
26. T. Nishimaki, O. Tanaka, T. Suzuki Patterns of lymphatic spread in thoracic esophageal cancer Cancer 74 1994 4 11
27. Y. Tajima, Y. Nakanishi, A. Ochiai Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma analysis of 240 surgically resected tumors Cancer 88 2000 1285 1293
28. M. Tachibana, H. Yoshimura, S. Kinugasa Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer Dig Liver Dis 33 2001 534 538
29. S. Natsugoe, H. Yoshinaka, M. Shimada Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma Ann Surg 234 2001 613 618
30. rd ed. 2002 The Registration Committee for Esophageal Cancer of JSDE Tokyo
31. J. Koch, R.A. Halvorsen Jr Staging of esophageal cancer computed tomography, magnetic resonance imaging, and endoscopic ultrasound Semin Roentgenol 29 1994 364 372
32. A.H. Holscher, H.J. Dittler, J.R. Siewert Staging of squamous esophageal cancer accuracy and value World J Surg 18 1994 312 320
33. J.D. Luketich, P. Schauer, R. Landreneau Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer J Thorac Cardiovasc Surg 114 1997 817 821
34. L.F. Wu, B.Z. Wang, J.L. Feng Preoperative TN staging of esophageal cancer comparison of miniprobe ultrasonography, spiral CT and MRI World J Gastroenterol 9 2003 219 224
35. J.V. Rasanen, E.I. Sihvo, M.J. Knuuti Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction Ann Surg Oncol 10 2003 954 960
36. J. Van Dam Endosonographic evaluation of the patient with esophageal cancer Chest 112 Suppl 4 1997 S184 S190
37. Y. Murata, M. Ohta, K. Hayashi Preoperative evaluation of lymph node metastasis in esophageal cancer Ann Thorac Cardiovasc Surg 9 2003 88 92
38. T.L. Tio, P.P. Coene, G.J. Luiken Endosonography in the clinical staging of esophagogastric carcinoma Gastrointest Endosc 36 1990 2 10
39. J.C. Souquet, B. Napoleon, B. Pujol Endosonography-guided treatment of esophageal carcinoma Endoscopy 24 1992 324 328
40. J. Vickers, D. Alderson Oesophageal cancer staging using endoscopic ultrasonography Br J Surg 85 1998 994 998